Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Biotechs continue attracting speculative capital as investors aggressively position around next-generation oncology, metabolic disease, and CNS therapy pla
-
Austin, TX, USA, May 21, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Genome Editing Market Size, Trends and Insights By Technology (CRISPR)/Cas9,...
-
Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Next Generation RNA Therapeutics Market (2nd Edition) by Type of Modality, Type of Molecule, Target Indication, Route of Administration, Geographical...
-
Austin, TX, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “RNA Targeting Small Molecule Drug Discovery Market Size, Trends and Insights By...
-
Austin, TX, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Targeted DNA RNA Sequencing Market Size, Trends and Insights By Technology (NGS,...
-
Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Ribonucleic Acid (RNA) Therapy Clinical Trials Market Report 2026" has been added to ResearchAndMarkets.com's offering. The RNA therapy clinical...
-
Dublin, April 17, 2026 (GLOBE NEWSWIRE) -- The "RNA Extraction and RNA Purification Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product, Application Area(s),...
-
Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "U.S. Exosomes Market Size, Share & Trends Analysis Report by Product & Service, Application, Workflow, End Use, and Segment Forecasts,...
-
Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Next Generation RNA Therapeutics Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Modality, Type of Molecule,...
-
Epigenetics Market is projected to grow from US$ 11.12 billion in 2024 to US$ 35.84 billion by 2031, registering a CAGR of 18.3%